Trevi Therapeutics (TRVI) PT Lowered to $18 at Morgan Stanley
Morgan Stanley analyst Judah Frommer ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)